Search results
Moderna's two-in-one flu and Covid vaccine passes advanced trial
BBC News· 5 days agoDrug company Moderna says its combined flu and Covid vaccine, which targets the two diseases in a...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 2 days agoBut the good news is that the newly dominant variants don’t appear more likely to cause severe...
What to know about Moderna’s combined covid-flu vaccine on the horizon
Boston.com· 4 days agoModerna’s combined coronavirus-influenza shot reportedly produced a higher immune response in older...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...
Moderna, Inc. (NASDAQ:MRNA) Insider Sells $766,810.02 in Stock
ETF DAILY NEWS· 3 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 5,178 shares of the company’s stock in a transaction dated Monday, June 10th. Following the ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 2 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
AOL· 5 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna, which is developing the experimental vaccine, announced Monday that in ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
Morningstar· 2 days agoNEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) ( ...
State of Tennessee Treasury Department Boosts Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoState of Tennessee Treasury Department increased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.5% in the fourth quarter, according to its most recent Form ...
Moderna's combo flu, COVID-19 shot succeeds in phase 3 trial
Becker’s Hospital Review· 5 days agoOn June 10, Moderna said its experimental combination vaccine for COVID-19 and influenza surpassed the efficacy of existing shots in a phase 3 trial. The company is the first ...